Future Prospects of the Minimal Residual Disease Testing Market Through 2035
The Minimal Residual Disease Testing Market is positioned for significant long-term growth as cancer diagnostics become increasingly focused on accuracy, sensitivity, and personalized patient management. Minimal residual disease testing is gaining recognition as an advanced approach for detecting small amounts of cancer that may remain after treatment. As healthcare providers continue to...
0 Comments 0 Shares 59 Views 0 Reviews